GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility

References

• Sahinovic MM, Struys M, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57(12):1539–1558.
   PubMed Web of Science ®Google Scholar
• Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des. 2004;10(29):3639–3649.
   PubMed Web of Science ®Google Scholar
• Iohom G, Ni Chonghaile M, O’Brien JK, Cunningham AJ, Fitzgerald DF, Shields DC. An investigation of potential genetic determinants of propofol requirements and recovery from anaesthesia. Eur J Anaesthesiol. 2007;24(11):912–919.
   PubMed Web of Science ®Google Scholar
• Takizawa D, Hiraoka H, Goto F, Yamamoto K, Horiuchi R. Human kidneys play an important role in the elimination of propofol. Anesthesiology. 2005;102(2):327–330.
   PubMed Web of Science ®Google Scholar
• Mikstacki A, Skrzypczak-Zielinska M, Tamowicz B, Zakerska-Banaszak O, Szalata M, Slomski R. The impact of genetic factors on response to anaesthetics. Adv Med Sci. 2013;58(1):9–14.
   PubMed Web of Science ®Google Scholar
• Rudolph U, Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci. 2004;5(9):709–720.
   PubMed Web of Science ®Google Scholar
• Guo C, Xie X, Li J, et al. Pharmacogenomics guidelines: current status and future development. Clin Exp Pharmacol Physiol. 2019;46(8):689–693.
   PubMed Web of Science ®Google Scholar
• Gardiner SJ, Begg EJ. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol Rev. 2006;58(3):521–590.
   PubMed Web of Science ®Google Scholar
• Lozupone M, Panza F, Stella E, et al. Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come? Expert Opin Drug Metab Toxicol. 2017;13(3):259–277.
   PubMed Web of Science ®Google Scholar
• Conti V, Corbi G, Manzo V, et al. The role of pharmacogenetics in antithrombotic therapy management: new achievements and barriers yet to overcome. Curr Med Chem. 2021;28(32):6675–6703.
   PubMed Web of Science ®Google Scholar
• Xie S, Ma W, Guo Q, et al. The pharmacogenetics of medications used in general anesthesia. Pharmacogenomics. 2018;19(3):285–298.
   PubMed Web of Science ®Google Scholar
• Morley AP, Papageorgiou CH, Marinaki AM, Cooper DJ, Lewis CM. The effect of pre-operative anxiety on induction of anaesthesia with propofol. Anaesthesia. 2008;63(5):467–473.
   PubMed Web of Science ®Google Scholar
• Polasek TM, Shakib S, Rostami-Hodjegan A. Precision dosing in clinical medicine: present and future. Expert Rev Clin Pharmacol. 2018;11(8):743–746.
   PubMed Web of Science ®Google Scholar
• Roden DM, McLeod HL, Relling MV, et al. Pharmacogenomics. Lancet. 2019;394(10197):521–532.
   PubMed Web of Science ®Google Scholar
• Robert F, Pelletier J. Exploring the impact of single-nucleotide polymorphisms on translation. Front Genet. 2018;9:507.
   PubMed Web of Science ®Google Scholar
• Pal N, Kertai MD. Perioperative precision medicine: where are we in 2020? Curr Opin Anaesthesiol. 2020;33(3):463–474.
   PubMed Web of Science ®Google Scholar
• Zorrilla-Vaca A, Healy RJ, Wu CL, Grant MC. Relation between bispectral index measurements of anesthetic depth and postoperative mortality: a meta-analysis of observational studies. Can J Anaesth. 2017;64(6):597–607.
   PubMed Web of Science ®Google Scholar
• Natarajan A, Strandvik GF, Pattanayak R, et al. Effect of ethnicity on the hypnotic and cardiovascular characteristics of propofol induction. Anaesthesia. 2011;66(1):15–19.
   PubMed Web of Science ®Google Scholar
• Desta Z, El-Boraie A, Gong L, et al. PharmVar GeneFocus: CYP2B6. Clin Pharmacol Ther. 2021;110(1):82–97.
   PubMed Web of Science ®Google Scholar
• Bach-Rojecky L, Vadunec D, Lozic M, et al. Challenges in anesthesia personalization: resolving the pharmacogenomic puzzle. Per Med. 2019;16(6):511–525.
   PubMed Web of Science ®Google Scholar
• Kansaku F, Kumai T, Sasaki K, et al. Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age. Drug Metab Pharmacokinet. 2011;26(5):532–537.
   PubMed Web of Science ®Google Scholar
• Mastrogianni O, Gbandi E, Orphanidis A, et al. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. Drug Metab Pharmacokinet. 2014;29(2):215–218.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Yokozuka M, Miyakawa H, Watanabe M, Kumai T, Tateda T. Effects of genetic polymorphism of CYP2B6 and UGT1A9 and sex differences on pharmacokinetics of propofol. J St Marianna Univ. 2015;6(2):183–193.
   Google Scholar
• Mourao AL, de Abreu FG, Fiegenbaum M. Impact of the Cytochrome P450 2B6 (CYP2B6) gene polymorphism c.516G>T (rs3745274) on propofol dose variability. Eur J Drug Metab Pharmacokinet. 2016;41(5):511–515.
   PubMed Web of Science ®Google Scholar
• Mikstacki A, Zakerska-Banaszak O, Skrzypczak-Zielinska M, et al. The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia. J Appl Genet. 2017;58(2):213–220.
   PubMed Web of Science ®Google Scholar
• Eugene AR. CYP2B6 genotype guided dosing of propofol anesthesia in the elderly based on nonparametric population pharmacokinetic modeling and simulations. Int J Clin Pharmacol Toxicol. 2017;6(1):242–249.
   PubMedGoogle Scholar
• Loryan I, Lindqvist M, Johansson I, et al. Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia. Eur J Clin Pharmacol. 2012;68(4):397–406.
   PubMed Web of Science ®Google Scholar
• Choong E, Loryan I, Lindqvist M, et al. Sex difference in formation of propofol metabolites: a replication study. Basic Clin Pharmacol Toxicol. 2013;113(2):126–131.
   PubMed Web of Science ®Google Scholar
• Kanaya A, Sato T, Fuse N, Yamaguchi H, Mano N, Yamauchi M. Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics. J Anesth. 2018;32(2):236–243.
   PubMed Web of Science ®Google Scholar
• Pavlovic D, Budic I, Jevtovic Stoimenov T, et al. The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on propofol pharmacokinetics in children. Pharmgenomics Pers Med. 2020;13:13–27.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ. Metabolic profiles of propofol and fospropofol: clinical and forensic interpretative aspects. Biomed Res Int. 2018;2018:6852857.
   PubMed Web of Science ®Google Scholar
• Wang YB, Zhang RZ, Huang SH, Wang SB, Xie JQ. Relationship between UGT1A9 gene polymorphisms, efficacy, and safety of propofol in induced abortions amongst Chinese population: a population-based study. Biosci Rep. 2017;37(5):BSR20170722.
   PubMedGoogle Scholar
• Girard H, Villeneuve L, Court MH, et al. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver. Drug Metab Dispos. 2006;34(7):1220–1228.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Tallapragada VJ, Chebib M, Johnston GAR, Hanrahan JR. GABA allosteric modulators: an overview of recent developments in non-benzodiazepine rs. Eur J Med Chem. 2019;171:434–461.
   PubMed Web of Science ®Google Scholar
• Zhu S, Noviello CM, Teng J, Walsh RM, Kim JJ, Hibbs RE. Structure of a human synaptic GABA receptor. Nature. 2018;559(7712):67–72.
   PubMed Web of Science ®Google Scholar
• Zhong Q, Chen X, Zhao Y, Liu R, Yao S. Association of polymorphisms in pharmacogenetic candidate genes with propofol susceptibility. Sci Rep. 2017;7(1):3343.
   PubMed Web of Science ®Google Scholar
• Bijker JB, van Klei WA, Kappen TH, van Wolfswinkel L, Moons KGM, Kalkman CJ. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107(2):213–220.
   PubMed Web of Science ®Google Scholar
• Milanez MIO, Silva AM, Perry JC, et al. Pattern of sympathetic vasomotor activity induced by GABAergic inhibition in the brain and spinal cord. Pharmacol Rep. 2020;72(1):67–79.
   PubMed Web of Science ®Google Scholar